Mobia Medical, Inc. (MOBI) – What Are Analysts Saying About This Stock?

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have earned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $20.75.

Several research firms recently commented on MOBI. BTIG Research reaffirmed a “buy” rating and set a $19.00 target price on shares of Mobia Medical in a report on Tuesday, October 20th. Weiss Ratings assumed coverage on Mobia Medical in a report on Wednesday, August 12th. They issued a “sell (e-)” rating for the company. Finally, JPMorgan Chase & Co. upped their price objective on Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th.

Insider Transactions at Mobia Medical

In other news, Director Casey Tansey purchased 16,441 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were purchased at an average cost of $12.07 per share, with a total value of $198,442.87. Following the completion of the acquisition, the director owned 318,332 shares of the company’s stock, valued at approximately $3,842,267.24. This represents a 5.45% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have acquired 87,000 shares of company stock worth $1,016,367 over the last quarter.

Institutional Investors Weigh In On Mobia Medical

Several hedge funds have recently modified their holdings of MOBI. Readystate Asset Management LP purchased a new position in Mobia Medical during the second quarter worth approximately $134,000. Citadel Advisors LLC acquired a new position in shares of Mobia Medical during the 2nd quarter worth approximately $670,000. State Street Corp acquired a new position in shares of Mobia Medical during the 2nd quarter worth approximately $735,000. Finally, University of Texas Texas AM Investment Management Co. purchased a new position in shares of Mobia Medical during the 3rd quarter valued at approximately $1,019,000.

Mobia Medical Price Performance

NASDAQ:MOBI opened at $9.97 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 13.28 and a quick ratio of 12.80. The business has a fifty day simple moving average of $9.98. Mobia Medical has a 1-year low of $8.03 and a 1-year high of $15.29. The firm has a market capitalization of $331.90 million and a price-to-earnings ratio of -0.49.

Mobia Medical (NASDAQ:MOBI) last posted its earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million for the quarter. The company’s revenue for the quarter was up 102.4% on a year-over-year basis. Equities analysts anticipate that Mobia Medical will post -2.63 EPS for the current fiscal year.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.